Acceder

ALBERTO BAROJA MAZO

Buscador

Hurtado-Navarro L, Baroja-Mazo A, Martínez-Banaclocha H, Pelegrín P. Assessment of ASC Oligomerization by Flow Cytometry. Methods Mol Biol. 2022;2459:1-9. doi: 10.1007/978-1-0716-2144-8_1. PubMed PMID: 35212949.
AÑO: 2022
Hurtado-Navarro L, Angosto-Bazarra D, Pelegrín P, Baroja-Mazo A, Cuevas S. NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers. Antioxidants (Basel). 2022 Apr 28;11(5). pii: 870. doi: 10.3390/antiox11050870. Review. PubMed PMID: 35624734.
AÑO: 2022; IF: 7.675
García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol. 2022 May 18;13:894470. doi: 10.3389/fimmu.2022.894470. eCollection 2022. PubMed PMID: 35663992; PubMed Central PMCID: PMC9161710.
AÑO: 2022; IF: 8.786
Tapiz I Reula AJ, Cochino AV, Martins AL, Angosto-Bazarra D, de Landazuri IO, Mensa-Vilaró A, Cabral M, Baroja-Mazo A, Baños MC, Lobato-Salinas Z, Fabregat V, Plaza S, Yagüe J, Casals F, Oliva B, Figueiredo AE, Pelegrín P, Aróstegui JI. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome. J Clin Immunol. 2022 Jun 18. doi: 10.1007/s10875-022-01298-2. [Epub ahead of print] Erratum in: J Clin Immunol. 2022 Jul 8;:. PubMed PMID: 35716229.
AÑO: 2022; IF: 8.542
López-López V, Pérez-Sánz F, de Torre-Minguela C, Marco-Abenza J, Robles-Campos R, Sánchez-Bueno F, Pons JA, Ramírez P, Baroja-Mazo A. Proteomics in Liver Transplantation: A Systematic Review. Front Immunol. 2021 Jul 26;12:672829. doi: 10.3389/fimmu.2021.672829. eCollection 2021. PubMed PMID: 34381445; PubMed Central PMCID: PMC8350337.
AÑO: 2021; IF: 8.786

Instituto de Investigación Sanitaria Acreditado

ISCII